Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zolpidem 10mg tablets
0401010Y0AAABAB
|
Zolpidem tartrate | Zolpidem tartrate | Central Nervous System | 80,594 |
|
Zolpidem 5mg tablets
0401010Y0AAAAAA
|
Zolpidem tartrate | Zolpidem tartrate | Central Nervous System | 51,437 |
|
Stilnoct 10mg tablets
0401010Y0BBABAB
|
Stilnoct | Zolpidem tartrate | Central Nervous System | 811 |
|
Stilnoct 5mg tablets
0401010Y0BBAAAA
|
Stilnoct | Zolpidem tartrate | Central Nervous System | 88 |
|
Zalzo 10mg orodispersible tablets
0401010Y0BCABAE
|
Zalzo | Zolpidem tartrate | Central Nervous System | No data available |
|
Zalzo 5mg orodispersible tablets
0401010Y0BCAAAD
|
Zalzo | Zolpidem tartrate | Central Nervous System | No data available |
|
Zolpidem 10mg orodispersible tablets sugar free
0401010Y0AAAEAE
|
Zolpidem tartrate | Zolpidem tartrate | Central Nervous System | No data available |
|
Zolpidem 5mg oral powder sachets
0401010Y0AAACAC
|
Zolpidem tartrate | Zolpidem tartrate | Central Nervous System | No data available |
|
Zolpidem 5mg orodispersible tablets sugar free
0401010Y0AAADAD
|
Zolpidem tartrate | Zolpidem tartrate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.